Medication and Polymedication in Portugal

  • Alexandra Pinto
  • Teresa Rodrigues
  • Jorge Mendes
  • Fernando Bação
  • Victor Lobo
Chapter
Part of the Studies in Theoretical and Applied Statistics book series (STAS)

Abstract

Portugal is a country with a high per capita consumption of medical drugs. High levels of medication implies not only risk to the patient but also a strong burden to the National Health Service (Serviço Nacional de Saúde—SNS). Polymedication, according to many authors, is the consumption of at least five different drugs. Polymedication can have serious consequences to the patient, if it is not well controlled. A project named MAISCINCO was created in order to make the population aware of the risks of polymedication. Our study used the data from the 4th National (Portuguese) Health Survey to estimate the consumption of multiple drugs, in particular polymedication, and to identify groups with greater risk of being polymedicated. We also aimed to represent geographically, at a NUTS II level, the prevalence of the more frequent kinds of drug consumption. As expected from the literature we found that women and older people have greater probability of being polymedicated, and this trend was observed and is similar in all regions. On the other hand, people in Madeira, Açores, and Algarve tend to use less medication.

Keywords

High Blood Pressure Drug Consumption National Health Survey Medical Drug Usual Residence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Abegunde, D.O., Mathers, C.D., et al.: The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370, 1929–1938 (2007)Google Scholar
  2. 2.
    Alto Comissariado da Saúde: Consumo de medicamentos ansiolíticos, hipnóticos e sedativos e antidepressivos no mercado do SNS, em ambulatório http://www.acs.min-saude.pt/pns/acessibilidade-ao-medicamento/health-impact-assessment/ (2009). Accessed 05 April 2010
  3. 3.
    Antunes, P.: Medicação crónica numa lista de utentes. Rev. Port. Clin. Geral. 23, 113–124 (2000)Google Scholar
  4. 4.
    Broeiro, P., Maio, I., et al.: Polifarmacoterapia: estratégias de racionalização. Rev. Port. Clin. Geral. 24, 625–631 (2008)Google Scholar
  5. 5.
    Bushardt, R.L., Massey, E.B., et al.: Polypharmacy: misleading, but manageable. Clin. Interv. Aging 3(2), 383–389 (2008)Google Scholar
  6. 6.
    Ferreira, R.: Consumo crónico de medicamentos na população de um Centro de Saúde. Rev. Port. Clin. Geral. 23, 125–132 (2007)Google Scholar
  7. 7.
    Galvão, C.: O idoso polimedicado – estratégias para melhorar a prescrição. Rev. Port. Clin. Geral. 22, 747–752 (2006)Google Scholar
  8. 8.
    INSA/INE: Inquérito Nacional de Saúde 2005/2006. Lisboa, INSA/INE (2010)Google Scholar
  9. 9.
    MAISCINCO: Polimedicação. http://www.maiscinco.com/a01.html (2008). Accessed 10 April 2010
  10. 10.
    Silva, P., Luís S., Biscaia A.: Polimedicação: um estudo de prevalência nos Centros de Saúde do Lumiar e de Queluz. Rev. Port. Clin. Geral. 20, 323–336 (2004)Google Scholar
  11. 11.
    Wolter, K.M.: Introduction to Variance Estimation. Springer, New York (2007)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Alexandra Pinto
    • 1
  • Teresa Rodrigues
    • 1
  • Jorge Mendes
    • 2
  • Fernando Bação
    • 3
  • Victor Lobo
    • 4
  1. 1.Laboratory of BiomathematicsFaculty of Medicine of LisbonLisboaPortugal
  2. 2.CEAUL, FCULUniversity of Lisbon, and ISEGILisboaPortugal
  3. 3.ISEGINew University of LisbonLisboaPortugal
  4. 4.ISEGINew University of Lisbon, and CINAV – Portuguese Navy Research Center, and Escola Naval – AlfeiteAlmadaPortugal

Personalised recommendations